David Lee Scher: Physicians, consumers must capitalize on mHealth tools

Mobile healthcare tech adoption is lagging for more than a few reasons, writes health technology consultant David Lee Scher, M.D., despite the fact big name tech companies are investing in the market.

In a recent post to his Digital Health Corner blog, Scher details five specific areas where apps and devices can make a difference for consumers and medical professionals. One of the most compelling is how mHealth tech can play a tremendous role in clinical trial efforts, from tracking patients in studies to improving safety.

"The ability to recruit more appropriate patients more rapidly via social media and wearable sensors using mobile technology has revolutionized the way we can conduct clinical trials," writes Scher, a clinical associate professor of medicine at the Pennsylvania State University College of Medicine. "Healthcare enterprise C-suite executives need to expand their horizons with respect to mobile health technologies." Article

Suggested Articles

The newly launched Center for Connected Health will be largest telehealth hub in the Philadelphia region, according to Penn Medicine.

The FDA commissioner wants to use additional funding under Trump's budget to advance digital health initiatives and integrate real-world data.

The FDA's approval of an app that uses AI to notify specialists of a potential stroke offers new possibilities for triage software that uses CDS.